Xanthus is a biopharmaceutical company.
Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 1, 2006 | Series B | $25M | 1 | — | — | Detail |
Dec 12, 2003 | Series B | $30.80M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
CDP Capital Technology Ventures | — | Series B |